RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAPELLO M
Collezione AOU Città della Salute di Torino

Items : 10

IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions. in Proceedings of the National Academy of Sciences of the United States of America / Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2020395118. doi: 10.1073/pnas.2020395118.

2021
AOU Città della Salute di Torino

Mucciolo G; Curcio C; Roux C; Li WY; Capello M; Curto R; Chiarle R; Giordano D; Satolli MA; Lawlor R; Scarpa A; Lukac P; Stakheev D; Provero P; Vannucci L; Mak TW; Novelli F; Cappello P;

Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. in Cancers / Cancers (Basel). 2020 Mar 21;12(3):746. doi: 10.3390/cancers12030746.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Hanash SM; Evangelista A; Satolli MA; Spadi R; Giordano D; Momin AA; Capello M; Hong W; Katayama H; Ferrero G; Follia L; Mandili G; Cordero F; Novelli F;

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. in Frontiers in oncology / Front Oncol. 2019 Feb 27;9:115. doi: 10.3389/fonc.2019.00115. eCollection 2019.

2019
AOU Città della Salute di Torino

Follia L; Ferrero G; Mandili G; Beccuti M; Giordano D; Spadi R; Satolli MA; Evangelista A; Katayama H; Hong W; Momin AA; Capello M; Hanash SM; Novelli F; Cordero F;

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8.

2017
AOU Città della Salute di Torino

Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F;

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia. in Oncotarget / Oncotarget. 2017 Jan 10;8(2):3274-3288. doi: 10.18632/oncotarget.13712.

2017
AOU Città della Salute di Torino

Griggio V; Mandili G; Vitale C; Capello M; Macor P; Serra S; Castella B; Peola S; Foglietta M; Drandi D; Omedé P; Sblattero D; Cappello P; Chiarle R; Deaglio S; Boccadoro M; Novelli F; Massaia M; Coscia M;

Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies. in Translational research : the journal of laboratory and clinical medicine / Transl Res. 2016 May;171:17-28.e1-2. doi: 10.1016/j.trsl.2015.12.013. Epub 2015 Dec 23.

2016
AOU Città della Salute di Torino

Alessio M; Novelli F; Amedei A; De Monte L; Álvarez-Fernández SM; Mautino A; Cassoni P; Ciccone G; Castiglione A; Alushi B; Chattaragada MS; Vallone R; Capello M; Caorsi C; Niccolai E;

Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. in Oncotarget / Oncotarget. 2016 Feb 2;7(5):5598-612. doi: 10.18632/oncotarget.6798.

2016
AOU Città della Salute di Torino

Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F;

Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation. in Immunology letters / Immunol Lett. 2015 Sep;167(1):11-6. doi: 10.1016/j.imlet.2015.06.008. Epub 2015 Jun 18.

2015
AOU Città della Salute di Torino

Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F;

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. in Journal of hematology & oncology / J Hematol Oncol. 2013 Sep 6;6:67. doi: 10.1186/1756-8722-6-67.

2013
AOU Città della Salute di Torino

Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F;

Three are better than one: plasminogen receptors as cancer theranostic targets. in Experimental hematology & oncology / Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12.

2013
AOU Città della Salute di Torino

Ceruti P; Principe M; Capello M; Cappello P; Novelli F;